Does DAPTOMYCIN Cause Diffuse large b-cell lymphoma refractory? 43 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 43 reports of Diffuse large b-cell lymphoma refractory have been filed in association with DAPTOMYCIN (daptomycin). This represents 0.5% of all adverse event reports for DAPTOMYCIN.
43
Reports of Diffuse large b-cell lymphoma refractory with DAPTOMYCIN
0.5%
of all DAPTOMYCIN reports
0
Deaths
43
Hospitalizations
How Dangerous Is Diffuse large b-cell lymphoma refractory From DAPTOMYCIN?
Of the 43 reports, 43 (100.0%) required hospitalization.
Is Diffuse large b-cell lymphoma refractory Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for DAPTOMYCIN. However, 43 reports have been filed with the FAERS database.
What Other Side Effects Does DAPTOMYCIN Cause?
Off label use (791)
Drug ineffective (658)
Product use in unapproved indication (654)
Eosinophilic pneumonia (575)
Acute kidney injury (501)
Blood creatine phosphokinase increased (461)
Pyrexia (447)
Eosinophilia (405)
Rhabdomyolysis (383)
Drug reaction with eosinophilia and systemic symptoms (307)
What Other Drugs Cause Diffuse large b-cell lymphoma refractory?
RITUXIMAB (461)
CYCLOPHOSPHAMIDE (360)
DOXORUBICIN (345)
VINCRISTINE (331)
ETOPOSIDE (244)
PREDNISONE (214)
EPCORITAMAB-BYSP (198)
CYTARABINE (193)
DEXAMETHASONE (170)
CISPLATIN (156)
Which DAPTOMYCIN Alternatives Have Lower Diffuse large b-cell lymphoma refractory Risk?
DAPTOMYCIN vs DARATUMUMAB
DAPTOMYCIN vs DARATUMUMAB\HYALURONIDASE-FIHJ
DAPTOMYCIN vs DARBEPOETIN ALFA
DAPTOMYCIN vs DARIDOREXANT
DAPTOMYCIN vs DARIFENACIN HYDROBROMIDE